| Advances in CRISPR therapeutics M Chavez, X Chen, PB Finn, LS Qi Nature Reviews Nephrology 19 (1), 9-22, 2023 | 117 | 2023 |
| Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro L Zeng, Y Liu, XH Nguyenla, TR Abbott, M Han, Y Zhu, A Chemparathy, ... Nature communications 13 (1), 2766, 2022 | 47 | 2022 |
| Stable expression of large transgenes via the knock-in of an integrase-deficient lentivirus M Chavez, DA Rane, X Chen, LS Qi Nature Biomedical Engineering, 1-11, 2023 | 20 | 2023 |
| The chromatin organization of a chlorarachniophyte nucleomorph genome GK Marinov, X Chen, T Wu, C He, AR Grossman, A Kundaje, ... Genome Biology 23 (1), 65, 2022 | 6 | 2022 |
| Genome-wide distribution of 5-hydroxymethyluracil and chromatin accessibility in the Breviolum minutum genome GK Marinov, X Chen, MP Swaffer, T Xiang, AR Grossman, WJ Greenleaf bioRxiv, 2023.09. 18.558303, 2023 | 4 | 2023 |
| Programmable drug control of receptor valency modulates the potency of cell therapeutics PB Finn, M Chavez, X Chen, H Wang, DA Rane, J Gurjar, LS Qi bioRxiv, 2023.01. 04.522664, 2023 | 2 | 2023 |
